Agilent Technologies, Inc.

$84.98
A - NYSE
Dividend yield
Dividend has grown by 11.65% in last three years.
0.85 %
$0.688 anually
P/E ratio
-
Payout ratio
Proportion of net income paid out as dividends to shareholders
-
Yearly
Company profitability (EPS)
-
past 12 months
CASH payout ratio
Agilent Technologies, Inc. last quarter cash income being paid in the form of dividends.
Last quarter
Become our supporter to unlock all data!
Stock volatility (Beta)
See how volatile A stock is compared to other dividend stocks and to its sector
past 12 months
Become our supporter to unlock all data!
Company debt level
How much debt Agilent Technologies, Inc. have in comparison to other dividend stocks
Become our supporter to unlock all data!
Agilent Technologies, Inc. description

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level.

The Diagnostics and Genomics segment comprises activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software, and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Company profile
Market cap
Mega (26.31B)
Company CEO
Michael R. McMullen
Price history Agilent Technologies, Inc.
Loading price stock history...
A dividends payouts
Similar stocks as Agilent Technologies, Inc.